Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | FWD1509 MsOH |
Synonyms | |
Therapy Description |
FWD1509 MsOH is a methanesulfonic acid formulation of the EGFR inhibitor FWD1509, which inhibits mutant forms of EGFR including exon 20 insertions, resulting in decreased downstream signaling and potentially leading to reduced tumor growth (NCI Thesaurus). |